Golden Rods

Gold nanoparticles are under consideration for a number of biomedical applications, such as tumor treatment. A German-American research team at Carnegie Mellon University in Pittsburgh, Hunter College in New York, and the RWTH Aachen has now developed a new method for the production of nanoscopic gold rods.

In contrast to previous methods, they have achieved this without the use of cytotoxic additives. As they report in the journal Angewandte Chemie, the synthesis is not carried out in water, but in an ionic liquid, a “liquid salt”.

Cancer cells are relatively temperature-sensitive. This is exploited in treatments involving overheating of parts of the cancer patient’s body. One highly promising method is photoinduced hyperthermia, in which light energy is converted to heat. Gold nanoparticles absorb light very strongly in the near infrared, a spectral region that is barely absorbed by tissue. The absorbed light energy causes the gold particles to vibrate and is dissipated into the surrounding area as heat. The tiny gold particles can be functionalized so that the specifically bind to tumor cells. Thus, only cells that contain gold particles are killed off.

The problem? Ordinary spherical gold particles do not efficiently convert the light energy into heat; only rod-shaped particles will do. Unfortunately, the additives needed to crystallize the rod-shaped particles from aqueous solutions are cytotoxic.

The team headed by Michael R. Bockstaller is now pursuing a new strategy: instead of aqueous solution, they chose to use an ionic liquid as their medium of crystallization. Ionic liquids are “liquid salts”, organic compounds that exist as oppositely charged ions, but in the liquid state. In this way, the researchers have been able to produce gold nanorods without the use of any cytotoxic additives.

In the first step, seed crystals are produced in the form of tiny spherical gold particles. These crystals are added to a “secondary growth solution” containing monovalent gold ions, silver ions, and the weak reducing agent ascorbic acid. The solvent is an imidazolium-based ionic liquid. In this medium, the crystals don’t continue to grow into spheres; instead they form rods with the round crystallization nuclei as “heads”. The mechanism is presumed to involve the various, energetically inequivalent surfaces of the crystal lattice: the aromatic, nitrogen-containing five-membered rings of the ionic liquid prefer to accumulate at the highly energetic facets of gold surfaces. They thus stabilize crystal shapes that have fewer low-energy facets than the normal spherical equilibrium form. This results in long rods.

Author: Michael R. Bockstaller, Carnegie Mellon University, Pittsburgh (USA), http://neon.mems.cmu.edu/people/bockstaller.htm

Title: Imidazolium-Based Ionic Liquids as Efficient Shape-Regulating Solvents for the Synthesis of Gold Nanorods

Angewandte Chemie International Edition 2008, 47, No. 40, doi: 10.1002/anie.200802185

Media Contact

Michael R. Bockstaller Angewandte Chemie

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Recovering phosphorus from sewage sludge ash

Chemical and heat treatment of sewage sludge can recover phosphorus in a process that could help address the problem of diminishing supplies of phosphorus ores. Valuable supplies of phosphorus could…

Efficient, sustainable and cost-effective hybrid energy storage system for modern power grids

EU project HyFlow: Over three years of research, the consortium of the EU project HyFlow has successfully developed a highly efficient, sustainable, and cost-effective hybrid energy storage system (HESS) that…

After 25 years, researchers uncover genetic cause of rare neurological disease

Some families call it a trial of faith. Others just call it a curse. The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare condition, but its…

Partners & Sponsors